StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by TheDudeAbideson Jun 28, 2019 12:47pm

156 Views

Post# 29874009

RE:RE:RE:TD trading

I think if the NR is what we all expect, a large Health Care Plan, we will not see .20 to agian. Any excess shares due day players will likely be consumed by traders buying on real news.

I think we may see a few weeks after NR of between .25-.35

Just my thoughts though, based only on what I know of the stock and past history.

For me, I will sell when it hits $2.00 and retire! Maybe I have to wait a couple of years, all good.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"